KENNEY CHRISTOPHER JOHN 4
4 · Xenon Pharmaceuticals Inc. · Filed Aug 25, 2021
Insider Transaction Report
Form 4
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-08-23+150,000→ 150,000 totalExercise: $16.64Exp: 2031-08-22→ Common Shares (150,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.